Dissecting Clonal Hematopoiesis in Tissues of Classical Hodgkin Lymphoma Patients

Clonal hematopoiesis predisposes to hematological malignancies. However, clonal hematopoiesis is understudied in classical Hodgkin lymphoma (cHL), a mature B-cell neoplasm exhibiting the most abundant microenvironment. We analyzed clonal hematopoiesis in 40 cHL cases by sequencing microdissected tum...

Full description

Saved in:
Bibliographic Details
Published inBlood cancer discovery Vol. 2; no. 3; pp. 216 - 225
Main Authors Venanzi, Alessandra, Marra, Andrea, Schiavoni, Gianluca, Milner, Sara G, Limongello, Roberto, Santi, Alessia, Pettirossi, Valentina, Ultimo, Simona, Tasselli, Luisa, Pucciarini, Alessandra, Falini, Lorenza, Sciabolacci, Sofia, Martelli, Maria Paola, Sportoletti, Paolo, Ascani, Stefano, Falini, Brunangelo, Tiacci, Enrico
Format Journal Article
LanguageEnglish
Published United States 01.05.2021
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Clonal hematopoiesis predisposes to hematological malignancies. However, clonal hematopoiesis is understudied in classical Hodgkin lymphoma (cHL), a mature B-cell neoplasm exhibiting the most abundant microenvironment. We analyzed clonal hematopoiesis in 40 cHL cases by sequencing microdissected tumor cells and matched normal cells from blood and/or lymph nodes. Five patients had blood and/or tissue clonal hematopoiesis. In three of five patients (all failing first-line therapy), clonal hematopoiesis spread through the tissue microenvironment extensively, and featured mutant , and + * in 33%, 92% and 60% of non-neoplastic cells, respectively. In the latter case, mutant clonal hematopoiesis seeded the neoplastic clone, which was infected by the Epstein-Barr virus and showed almost no other somatic mutations exome-wide. In the former case, -mutant clonal hematopoiesis did not originate the neoplastic clone despite dominating the blood and B-cell lineage (~94% leukocytes; ~96% mature blood B cells), yet led to -mutated acute myeloid leukemia 6 years after therapy for cHL. Our results expand to cHL the spectrum of hematologic malignancies associated with clonal hematopoiesis.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:2643-3249
DOI:10.1158/2643-3230.BCD-20-0203